These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8139148

  • 1. [Nephropathy in patients with primary antiphospholipid antibody syndrome].
    Yoshida A, Morozumi K, Takeda A, Koyama K, Ideura T, Oikawa T.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):158-62. PubMed ID: 8139148
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG, Sotsiou F, Moutsopoulos HM.
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [Abstract] [Full Text] [Related]

  • 5. [Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].
    Shilov EM, Kozlovskaia NL, Meteleva NA, Kozlovskaia LV, Varshavskiĭ VA, Miroshnichenko NG, Blokhina GV, Serova AG, Nesterova SG, Smolianitskiĭ AIa.
    Ter Arkh; 2003 Oct; 75(6):22-7. PubMed ID: 12920954
    [Abstract] [Full Text] [Related]

  • 6. Renal involvement in primary antiphospholipid syndrome.
    Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA.
    J Rheumatol; 1992 Aug; 19(8):1181-5. PubMed ID: 1404151
    [Abstract] [Full Text] [Related]

  • 7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 8. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 9. Renal damage in systemic lupus erythematosus with normal renal function.
    Hollcraft RM, Dubois EL, Lundberg GD, Chandor SB, Gilbert SB, Quismorio FP, Barbour BH, Friou GJ.
    J Rheumatol; 1976 Sep; 3(3):251-61. PubMed ID: 789881
    [Abstract] [Full Text] [Related]

  • 10. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
    Naseeb F, Arfaj AA, Hamdani A, Kfoury H, Parvez K, Mogairen SA.
    J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
    [Abstract] [Full Text] [Related]

  • 11. Kidney disease in antiphospholipid syndrome.
    Amigo MC.
    Rheum Dis Clin North Am; 2006 Aug; 32(3):509-22. PubMed ID: 16880081
    [Abstract] [Full Text] [Related]

  • 12. Identification and treatment of APS renal involvement.
    Tektonidou MG.
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [Abstract] [Full Text] [Related]

  • 13. [Anti-phospholipid syndrome nephropathy].
    Nochy D, Daugas E, Hill G, Piette JC.
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 17. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S, Kobayashi Y, Shigematsu H, Hiki Y.
    Q J Med; 1983 Dec; 52(207):311-31. PubMed ID: 6359226
    [Abstract] [Full Text] [Related]

  • 18. [Nephropathy in patients with mixed connective tissue disease].
    Yoshida A, Morozumi K, Takeda A, Koyama K.
    Ryumachi; 1994 Dec; 34(6):976-80. PubMed ID: 7863388
    [Abstract] [Full Text] [Related]

  • 19. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R, Feng PH.
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [Abstract] [Full Text] [Related]

  • 20. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.